{
    "clinical_study": {
        "@rank": "65426", 
        "arm_group": [
            {
                "arm_group_label": "Catalys Treated Eyes", 
                "arm_group_type": "Active Comparator", 
                "description": "Patient's aged 22 and older with visually significant cataracts undergoing Femtosecond Laser Assisted Cataract Surgery with Catalys Laser."
            }, 
            {
                "arm_group_label": "LenSx Treated Eyes", 
                "arm_group_type": "Active Comparator", 
                "description": "Patient's aged 22 and older with visually significant cataracts undergoing Femtosecond Laser Assisted Cataract Surgery with LenSx Laser."
            }
        ], 
        "brief_summary": {
            "textblock": "This study compares two FDA approved Cataract Lasers."
        }, 
        "brief_title": "The Comparison of Cataract Lasers Using the Optimedica Catalys Laser and the Alcon LenSx Laser.", 
        "completion_date": {
            "#text": "September 2013", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Nuclear Sclerosis of the Lens", 
            "Posterior Subcapsular Cataract", 
            "Cortical Cataract"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Sclerosis", 
                "Cataract"
            ]
        }, 
        "detailed_description": {
            "textblock": "The purpose of this study is to systematically evaluate the performance of two commercially\n      available and FDA cleared femtosecond laser systems in patients undergoing femtosecond\n      laser-assisted cataract surgery.  Objective data on the repeatability and accuracy of the\n      studied parameters will be gathered and reported as endpoints of the study.\n\n      The two systems studied are the Catalys\u2122 Precision Laser System (OptiMedica, CA, USA) and\n      the LenSx\u00ae Laser System (Alcon Laboratories, Inc., Fort Worth, TX).\n\n      Published data have suggested that the femtosecond laser is a useful tool for cataract\n      surgery.\n\n      This study is to determine whether differences or similarities exist in specific treatment\n      parameters achieved with two FDA cleared and commercially available femtosecond laser\n      cataract surgery platforms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Have grade 2 to 4 nuclear sclerotic and or cortical or posterior subcapsular\n             cataracts with visual impairment.\n\n          -  Pupillary dilation of at least 6.0 mm\n\n          -  Axial length between 21 mm to 26 mm\n\n          -  Age \u2265 22 years of either gender\n\n          -  Require laser assisted corneal incisions, capsulotomy and nucleus segmentation\n\n          -  Understand and sign a written Informed Consent form\n\n          -  Be able to comply with the treatment and follow-up schedule\n\n        Exclusion Criteria:\n\n          -  Enrolment in another drug or device study within the prior 3 months\n\n          -  History of ocular trauma\n\n          -  Acute or chronic disease or illness that would increase risk or confound study\n             results (e.g., uncontrolled diabetes mellitus, immunocompromised, etc.)\n\n          -  Uncontrolled systemic or ocular disease\n\n          -  Corneal abnormalities (e.g., stromal, epithelial or endothelial dystrophies, severe\n             corneal opacities, significant corneal edema, etc)\n\n          -  Diminished aqueous clarity that obscures OCT imaging of the anterior lens capsule\n\n          -  Corneal ring and/or inlay implant(s)\n\n          -  Pseudoexfoliation\n\n          -  Known steroid IOP responder or ocular hypertension IOP >25 mmHg by tonometry\n\n          -  Retinal detachment within the last 6 months\n\n          -  Anterior chamber depth less than 2.5 mm"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "22 Years"
        }, 
        "enrollment": {
            "#text": "50", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "June 12, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01878838", 
            "org_study_id": "HV-AVO1"
        }, 
        "intervention": [
            {
                "arm_group_label": "Catalys Treated Eyes", 
                "description": "Cohort subjects will undergo Femtosecond Laser Assisted Cataract Surgery in both eyes, with the Optimedica Catalys laser on one eye, and the Alcon LensX laser on the other. First eyes will be randomized.", 
                "intervention_name": "Femtosecond Laser Assisted Cataract Surgery with Catalys Laser", 
                "intervention_type": "Procedure", 
                "other_name": "Optimedica Catalys Precision Laser System"
            }, 
            {
                "arm_group_label": "LenSx Treated Eyes", 
                "description": "Cohort subjects will undergo Femtosecond Laser Assisted Cataract Surgery in both eyes, with the Optimedica Catalys laser on one eye, and the Alcon LensX laser on the other. First eyes will be randomized.", 
                "intervention_name": "Femtosecond Laser Assisted Cataract Surgery with LenSx Laser", 
                "intervention_type": "Procedure", 
                "other_name": "Alcon LenSx Laser System"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "June 13, 2013", 
        "location": {
            "contact": {
                "email": "steve@hoopesvision.com", 
                "last_name": "Steve H Linn, OD", 
                "phone": "801-568-0200", 
                "phone_ext": "7343"
            }, 
            "contact_backup": {
                "email": "nicole@hoopesvision.com", 
                "last_name": "Nicole Q Adams, COA", 
                "phone": "(801) 568-0200", 
                "phone_ext": "7342"
            }, 
            "facility": {
                "address": {
                    "city": "Salt Lake City", 
                    "country": "United States", 
                    "state": "Utah", 
                    "zip": "84020"
                }, 
                "name": "Hoopes Vision"
            }, 
            "investigator": [
                {
                    "last_name": "Robert P Rivera, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Phillip C Hoopes, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospective Randomized Controlled Clinical Trial Comparing the Intra-operative Effects, Safety, Efficacy and Performance of Two Commercially Available Laser Systems in Patients Undergoing Femtosecond Laser-Assisted Cataract Surgery.", 
        "overall_contact": {
            "email": "steve@hoopesvision.com", 
            "last_name": "Steve H Linn, OD", 
            "phone": "(801) 568-0200", 
            "phone_ext": "7343"
        }, 
        "overall_contact_backup": {
            "email": "nicole@hoopesvision.com", 
            "last_name": "Nicole Q Adams, COA", 
            "phone": "(801) 568-0200", 
            "phone_ext": "7342"
        }, 
        "overall_official": [
            {
                "affiliation": "Hoopes Vision", 
                "last_name": "Robert P Rivera, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hoopes Vision", 
                "last_name": "Steve H Linn, OD", 
                "role": "Study Director"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "The total amount of phacoemulsification energy delivered during the procedure.", 
            "measure": "Cumulative Dissipated Energy", 
            "safety_issue": "No", 
            "time_frame": "Intraoperative"
        }, 
        "reference": [
            {
                "PMID": "19294964", 
                "citation": "Cullen KA, Hall MJ, Golosinskiy A. Ambulatory surgery in the United States, 2006. Natl Health Stat Report. 2009 Jan 28;(11):1-25."
            }, 
            {
                "PMID": "22520307", 
                "citation": "Vasavada AR, Vasavada V, Vasavada VA, Praveen MR, Johar SR, Gajjar D, Arora AI. Comparison of the effect of torsional and microburst longitudinal ultrasound on clear corneal incisions during phacoemulsification. J Cataract Refract Surg. 2012 May;38(5):833-9. doi: 10.1016/j.jcrs.2011.11.050."
            }, 
            {
                "PMID": "18343350", 
                "citation": "Georgescu D, Kuo AF, Kinard KI, Olson RJ. A fluidics comparison of Alcon Infiniti, Bausch & Lomb Stellaris, and Advanced Medical Optics Signature phacoemulsification machines. Am J Ophthalmol. 2008 Jun;145(6):1014-1017. doi: 10.1016/j.ajo.2008.01.024. Epub 2008 Mar 17."
            }, 
            {
                "PMID": "16698480", 
                "citation": "Dooley IJ, O'Brien PD. Subjective difficulty of each stage of phacoemulsification cataract surgery performed by basic surgical trainees. J Cataract Refract Surg. 2006 Apr;32(4):604-8."
            }, 
            {
                "PMID": "2299571", 
                "citation": "Gimbel HV, Neuhann T. Development, advantages, and methods of the continuous circular capsulorhexis technique. J Cataract Refract Surg. 1990 Jan;16(1):31-7."
            }, 
            {
                "PMID": "21700099", 
                "citation": "Friedman NJ, Palanker DV, Schuele G, Andersen D, Marcellino G, Seibel BS, Batlle J, Feliz R, Talamo JH, Blumenkranz MS, Culbertson WW. Femtosecond laser capsulotomy. J Cataract Refract Surg. 2011 Jul;37(7):1189-98. doi: 10.1016/j.jcrs.2011.04.022. Erratum in: J Cataract Refract Surg. 2011 Sep;37(9):1742."
            }, 
            {
                "PMID": "19781460", 
                "citation": "Artz\u00e9n D, Lundstr\u00f6m M, Behndig A, Stenevi U, Lydahl E, Montan P. Capsule complication during cataract surgery: Case-control study of preoperative and intraoperative risk factors: Swedish Capsule Rupture Study Group report 2. J Cataract Refract Surg. 2009 Oct;35(10):1688-93. doi: 10.1016/j.jcrs.2009.05.026."
            }, 
            {
                "PMID": "18675698", 
                "citation": "Bellini LP, Brum GS, Grossi RS, Borowsky C. Cataract surgery complication rates. Ophthalmology. 2008 Aug;115(8):1432; author reply 1432-3. doi: 10.1016/j.ophtha.2008.04.009."
            }, 
            {
                "PMID": "18245961", 
                "citation": "Richard J, Hoffart L, Chavane F, Ridings B, Conrath J. Corneal endothelial cell loss after cataract extraction by using ultrasound phacoemulsification versus a fluid-based system. Cornea. 2008 Jan;27(1):17-21. doi: 10.1097/ICO.0b013e3181583115."
            }, 
            {
                "PMID": "8915805", 
                "citation": "Hayashi K, Hayashi H, Nakao F, Hayashi F. Risk factors for corneal endothelial injury during phacoemulsification. J Cataract Refract Surg. 1996 Oct;22(8):1079-84."
            }, 
            {
                "PMID": "22081031", 
                "citation": "Uy HS, Edwards K, Curtis N. Femtosecond phacoemulsification: the business and the medicine. Curr Opin Ophthalmol. 2012 Jan;23(1):33-9. doi: 10.1097/ICU.0b013e32834cd622. Review."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01878838"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Hoopes Vision", 
            "investigator_full_name": "Robert P Rivera, MD", 
            "investigator_title": "Director of Clinical Research", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "description": "Did the laser perform a complete capsulotomy with no tags or untreated segments.", 
            "measure": "Complete Laser Capsulotomy", 
            "safety_issue": "No", 
            "time_frame": "Intraoperative"
        }, 
        "source": "Hoopes Vision", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Robert P Rivera, MD", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}